Institute for Global Health Studies, University of California, San Francisco, CA.
Eastern Deanery AIDS Relief Programme, Nairobi, Kenya.
J Acquir Immune Defic Syndr. 2020 May 1;84(1):5-9. doi: 10.1097/QAI.0000000000002317.
Serological tests can distinguish recent (in the prior 12 months) from long-term HIV infection. Integrating recency testing into routine HIV testing services (HTS) can provide important information on transmission clusters and prioritize clients for partner testing. This study assessed the feasibility and use of integrating HIV recency into routine testing.
We conducted a multi-method study at 14 facilities in Kenya, and key informant interviews with health care providers. We abstracted clinical record data, collected specimens, tested specimens for recent infection, returned results to participants, and conducted a follow-up survey for those recently infected.
From March to October 2018, we enrolled 532 clients who were diagnosed HIV-positive for the first time. Of these, 46 (8.6%) were recently infected. Women aged 15-24 years had 2.9 (95% confidence interval: 1.46 to 5.78) times higher adjusted odds of recent infection compared with 15-24-year-old men and those tested within the past 12 months having 2.55 (95% confidence interval: 0.38 to 4.70) times higher adjusted odds compared with those tested ≥12 months previously. Fourteen of 17 providers interviewed found the integration of recency testing into routine HTS services acceptable and feasible. Among clients who completed the follow-up interview, most (92%) felt that the recency results were useful.
Integrating recent infection testing into routine HTS services in Kenya is feasible and largely acceptable to clients and providers. More studies should be done on possible physical and social harms related to returning results, and the best uses of the recent infection data at an individual and population level.
血清学检测可区分近期(过去 12 个月内)和长期 HIV 感染。将近期感染检测纳入常规 HIV 检测服务(HTS)中,可以提供有关传播集群的重要信息,并优先为伴侣检测确定客户。本研究评估了将 HIV 近期感染纳入常规检测的可行性和应用。
我们在肯尼亚的 14 个设施中进行了一项多方法研究,并对医疗保健提供者进行了关键知情人访谈。我们提取临床记录数据,采集标本,检测近期感染的标本,将结果返回给参与者,并对那些新近感染的人进行了后续调查。
2018 年 3 月至 10 月,我们招募了首次诊断为 HIV 阳性的 532 名患者。其中,46 人(8.6%)为近期感染。15-24 岁的女性与 15-24 岁的男性相比,最近感染的调整后优势比为 2.9(95%置信区间:1.46 至 5.78),而在过去 12 个月内接受检测的人最近感染的调整后优势比为 2.55(95%置信区间:0.38 至 4.70),与过去 12 个月以上接受检测的人相比。在接受访谈的 17 名提供者中,有 14 名发现将近期感染检测纳入常规 HTS 服务是可接受且可行的。在完成随访访谈的患者中,大多数(92%)认为近期检测结果有用。
在肯尼亚,将近期感染检测纳入常规 HTS 服务是可行的,并且患者和提供者普遍接受。应进一步研究与结果回报相关的实际和社会危害,以及在个人和人群层面上使用近期感染数据的最佳方法。